In this review, we will discuss the immunological basis for psoriasis with special emphasis on the role of effector T cells. With the understanding of this immunologic process, we will present a model for the development of targeted immune response modifiers, termed biologic immunotherapies, and their potential role for the benefit of patients with psoriasis.
|Original language||English (US)|
|Number of pages||7|
|Journal||Journal of the American Academy of Dermatology|
|Issue number||2 A|
|State||Published - Aug 1 2003|
ASJC Scopus subject areas